AstraZeneca PLC LSE:AZN:
ASTRAZENECA - REPORTS FAVOURABLE SAFETY PROFILE FOR EFZIMFOTASE ALFA IN PHASE III HPP TRIALS
Reuters
Astrazeneca Reports Favourable Safety Profile For Efzimfotase Alfa In Phase III HPP Trials
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- LSE:AZN
- Language
- English
AstraZeneca PLC LSE:AZN: